'31% of those who have yet to receive a shot said they would be more likely to do so after the FDA gave full approval. Fantastic. Now they have no excuse to not get a shot of the Pfizer vaccine, other than finding one,' writes The Times Editorial Board.
The Pfizer-BioNTech COVID-19 vaccine was the first to receive an emergency use authorization by the U.S. Food and Drug Administration in December. And as of Monday, it is the first COVID-19 vaccine to receiveIt’s a milestone moment in the prolonged public health crisis. The status upgrade may not affect the lives of people who have already received one or two of the 200 million Pfizer doses that have been administered in the U.S.
Fantastic. Now they have no excuse to not get a shot of the Pfizer vaccine, other than finding one. Moderna could receive full approval for its mRNA vaccine as soon as next month.Still, approval may not be enough to motivate procrastinators who are rooted in a foolish misbelief they aren’t at risk. Everyone who is human is at risk of COVID-19 infection, hospitalization, serious long-term effects and death — but all of those outcomes are greatly reduced by vaccination.
As unpopular as they may be, mandates work. After Gov. Gavin Newsom and mayors in major cities including Los Angeles announced new vaccination requirements for government employees and workers in healthcare facilities, the pace of inoculation in California rose immediately. And we will need more mandates to stop the current surge before it gets worse.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19: Eleven more Covid-related deaths and 1,485 new casesThe total number of deaths linked to Covid-19 in NI since the start of the pandemic is now 2,302.
Weiterlesen »
Covid: Government warns Covid test firms over misleading pricesMore than 80 Covid test firms are issued with warnings and could be taken off the government's website.
Weiterlesen »
Pfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Gov’t FindsA third shot of the Pfizer vaccine dramatically reduced the risk of Covid-19 infection and subsequent hospitalization among people who are older than 60.
Weiterlesen »
Pfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Data ShowsPfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Gov’t Finds
Weiterlesen »
FDA could grant full approval to Pfizer/BioNTech Covid-19 vaccine today, two officials sayCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Weiterlesen »
UK orders 35 million more Pfizer/BioNTech COVID vaccinesBritain has agreed to buy 35 million more doses of the Pfizer/BioNTech (22UAy.DE) COVID-19 vaccine, to be delivered from the second half of next year, as part of its preparations for booster shots and any new variants that could emerge.
Weiterlesen »